Machine Learning and Single-Cell Technology Combined to Drive High-Performance Cell Line Development
The integrated approach is designed to adapt to the evolving needs of new therapeutic modalities, delivering both speed and performance.
OneCyte, a leader in high-throughput single-cell analysis and cell line development technologies, and Kemp Proteins, a ...
The key for optimizing cell-line development for antibody derivatives might just be to prioritize early assessment of product ...
Once physical security measures are circumvented, there are no measures in place to protect cells from theft, abuse, or unauthorized use.
Applied StemCell, Inc. (“ASC”), a genome engineering company with deep expertise in induced pluripotent stem cell (iPSC) technology and Cellipont Bioservices, a cell therapy contract development and ...
WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc. (NYSE: PKI) (“PerkinElmer”) and Horizon Discovery Group plc (LSE: HZD) (“Horizon”) are pleased to announce that they have reached an agreement on the ...
Widely used as a genome editing tool, the CRISPR-Cas9 system allows researchers to precisely induce frameshift mutations in specific genes or insert foreign nucleic acid sequences into a cell’s DNA.
WUHAN, HUBEI PROVINCE, CHINA, February 15, 2026 /EINPresswire.com/ — In the complex landscape of life science research, selecting the right cellular model is a ...
For the first time, researchers at the University of British Columbia have demonstrated how to reliably produce an important type of human immune cell—known as helper T cells—from stem cells in a ...
A study published in Stem Cell Reports demonstrates that genetically engineered human pluripotent stem cells (hPSCs) can overcome immune rejection in mice with humanized immune systems, surviving for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results